• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Yilun, ZHAO Xinyi, DONG Shubo, DONG Chao, SHEN Wenbin, DONG Haijuan. Isolation and identification of unknown impurities of alogliptin benzoate[J]. Journal of China Pharmaceutical University, 2020, 51(4): 488-493. DOI: 10.11665/j.issn.1000-5048.20200415
Citation: ZHANG Yilun, ZHAO Xinyi, DONG Shubo, DONG Chao, SHEN Wenbin, DONG Haijuan. Isolation and identification of unknown impurities of alogliptin benzoate[J]. Journal of China Pharmaceutical University, 2020, 51(4): 488-493. DOI: 10.11665/j.issn.1000-5048.20200415
shu

Isolation and identification of unknown impurities of alogliptin benzoate

  • 1.

    Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009

  • 2.

    Jiangsu Deyuan Pharmaceutical Co.,Ltd., Lianyungang 222000, China

More Information
  • Received Date: June 04, 2020
    Graphical Abstract
    • Abstract
  • By silica gel column chromatography, solvent extraction and preparative high performance liquid chromatography (HPLC), four new related substance were isolated and purified from the mass production and preparation process of alogliptin benzoate. Then it was analyzed and confirmed by various spectrum identification methods such as nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HR-MS) and Fourier-transform infrared spectroscopy (FTIR) according to its physical and chemical properties. The chemical structures of the four related substances produced in each step of the synthesis process of alogliptin benzoate were determined, and they were named as impurities L, M, T, and V. These four related substances were new impurities which were found for the first time. The isolation and identification of these impurities are of great importance to the quality control of alogliptin benzoate, and the optimization of manufacturing process.
    • FullText(HTML)
    • References (11)
  • [1]
    Feng J，Zhang Z，Wallace M B，et al. Discovery of alogliptin: a potent，selective，bioavailabe and efficacious inhibitor of dipeptidyl peptidase IV[J]. J Med Chem，2007，50(10):2297-2300.
    [2]
    Zhang SF. Approval for marketing of the new diabetes drug，NESINA[J]. Chin Lic Pharm（中国执业药师），2010，12(6):54.
    [3]
    Scott L J.Alogliptin: a review of its use in the management of type 2 diabetes mellitus[J]. Drugs, 2010, 70(18):2051-2072.
    [4]
    Li RF，Ouyang XY，lv F，et al.Analysis for patents of anti-diabetic dipeptidyl peptidase inhibitors[J]. Chin New Drugs J（中国新药杂志），2015，24(1):8-17.
    [5]
    Shen D，Wang ZJ，Xu C，et al.Synthesis of alogliptin benzoate and its preliminary quality control[J]. Central South Pharm（中南药学），2016，14(9):813-816.
    [6]
    Lu YT，Yang DY ，Li ZY，et al. Isolation and characterization of related substances in alogliptin benzoate by LC-QTOF mass spectrometric techniques[J]. J Pharm Biomed Anal，2016，128:253-263.
    [7]
    Zhang K，Ma PQ，Jing WN，et al. A developed HPLC method for the determination of alogliptin benzoate and its potential impurities in bulk drug and tablets[J]. Asian J Pharm Sci，2015，10:152-158.
    [8]
    Zhou XY，Rong R，ZhaoYL，et al. Determination of related substances in alogliptinbenzoate by HPLC[J].J Shenyang Pharm Univ（沈阳药科大学学报），2016，33(6):444-449.
    [9]
    Sun ZY，Qiao SQ，Luo ZL，Determination of related substances in alogliptin benzoate raw materials by HPLC [J].J China Pharm（中国药房），2014，25(33)：3141-3143.
    [10]
    Shao J，Gao S，Li XX，et al.Determination of alogliptin benzoate and its related substances [J]. J Shenyang Pharm Univ（沈阳药科大学学报），2015，32(10):780-785.
    [11]
    Liu ZW，Wu LH，Wang EJ.Synthesis of alogliptin benzoate [J]. Strait Pharm（海峡药学），2011，23(9):214-215.
    • Related Articles

  • Related Articles

    [1]QIAN Qianqian, LI Guozhi, TIAN Hong, GAO Xiangdong. Design, preparation, and antitumor activity of fusion protein vaccine based on tumor antigen PBK[J]. Journal of China Pharmaceutical University, 2024, 55(5): 657-665. DOI: 10.11665/j.issn.1000-5048.2024030801
    [2]ZHOU Hongyou, GAO Xiangdong, YAO Wenbing, TIAN Hong. Screening of adjuvant for PD-L1 vaccine based on nitrated T cell epitope[J]. Journal of China Pharmaceutical University, 2024, 55(3): 397-403. DOI: 10.11665/j.issn.1000-5048.2023032801
    [3]LI Mengyuan, JIANG Xiaomeng, SUN Qinyi, GUO Wei. Research progress of CAR-T immunotherapy in solid tumors combined with new strategies[J]. Journal of China Pharmaceutical University, 2023, 54(4): 443-449. DOI: 10.11665/j.issn.1000-5048.2023030101
    [4]SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803
    [5]WANG Zhenghao, GAO Yafeng, ZHANG Lianjun, LIU Chang. Research progress of T cell anti-tumor function regulated by endoplasmic reticulum stress[J]. Journal of China Pharmaceutical University, 2022, 53(5): 518-524. DOI: 10.11665/j.issn.1000-5048.20220502
    [6]YAO Zheng, LI Zihan, GAO Liming, HU Xing, CHEN Yan, PAN Wenqi, LI Qian. Advances of research on CAR-T cell immunotherapy for solid tumors[J]. Journal of China Pharmaceutical University, 2021, 52(4): 496-504. DOI: 10.11665/j.issn.1000-5048.20210413
    [7]XIA Xuefei, ZHANG Li, LUO Jianhua, YAO Wenbing, GAO Xiangdong, TIAN Hong. Design and antitumor activity of immune checkpoint B7-H3 epitope vaccine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 472-479. DOI: 10.11665/j.issn.1000-5048.20210410
    [8]CHEN Hongmei, KANG Yanliang, LIU Li, YAO Wenbing, TIAN Hong. Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets[J]. Journal of China Pharmaceutical University, 2020, 51(3): 349-356. DOI: 10.11665/j.issn.1000-5048.20200313
    [9]JIANG Liangliang, JIANG Tao, LUO Jianhua, YAO Wenbing, TIAN Hong. A novel human immune system mice model for assessing the immunogenicity of cancer vaccines[J]. Journal of China Pharmaceutical University, 2019, 50(6): 734-742. DOI: 10.11665/j.issn.1000-5048.20190615
    [10]SUN Zhan-yi, CAI Hui, HUANG Zhi-hua, SHI Lei, CHEN Yong-xiang, LI Yan-mei. Advances of glycopeptide-associated tumor vaccines[J]. Journal of China Pharmaceutical University, 2012, 43(2): 97-106.

Catalog

    Get Citation
    PDF
    XML
    Article views (222) PDF downloads (377) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365820

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return